Aus outcomes 'excellent' for multidrug-resistant TB
But respiratory physicians warn that adverse events are frequent and close monitoring of patients is essential
Individualised therapy for patients with multidrug-resistant tuberculosis results in a high rate of treatment completion, Sydney doctors have found after a retrospective study.
However, among the cohort of 55 patients seen consecutively over 17 years, each experienced at least one adverse event, with ototoxicity the most common.
Only 2% of cases of TB in Australia are multidrug-resistant, and these patients undergo therapy tailored to the drug
